Adam Boxer
Physician · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
- 1999–2003
Neurology
Research
Neuron · 2011 · 4,040 citations
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Movement Disorders · 2017 · 1,934 citations
209 papers
- HR
152 papers
- JK
138 papers
114 papers
112 papers
83 papers · 2 as a fellow
73 papers
- AS
71 papers
Grants
- 2019–2030
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
National Institute on Aging · U19
PI · $102.2M · Mayo Clinic Rochester
- 2023–2030
The Alzheimer's Disease Tau Platform Clinical Trial
National Institute on Aging · R01
Contact PI · $60.7M · University of California, San Francisco
- 2024–2030
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)
National Institute on Aging · R01
Contact PI · $30.3M · University of California, San Francisco
- 2022–2029
Phase IIB: A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration Syndromes
National Institute on Aging · R44
PI · $1M · Biosensics, Llc
Clinical trials
- 2026–2028
Alzheimer's Tau Platform: Regimen A - AADvac1
Principal investigator · Enrolling by invitation · Phase 2
Paul S. Aisen
- 2026–2030
The Progressive Supranuclear Palsy Clinical Trial Platform
Principal investigator · Recruiting · Phase 2
Adam Boxer
- 2026–2030
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
Principal investigator · Enrolling by invitation · Phase 2
Adam Boxer
- 2026–2030
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
Principal investigator · Enrolling by invitation · Phase 2
Adam Boxer